Introduction
, have been shown to kill cancer cells in a light-dependent fashion by a mechanism distinctly different from that of cisplatin. [3] Structure activity relationships show that all-trans Pt IV diazides are also active; in fact we have found that compounds 3 and 4 are even more potent than their cis,trans,cis isomers when activated by light. [3, 4] Furthermore, when ammine or alkyl amine ligands are replaced by pyridine, a 10-fold increase in cytotoxicity is observed when the complexes are irradiated with UVA light. [5] This effect could be related to the decrease in basicity of the coordinating pyridine compared to an ammine or a primary amine ligand. However, introduction of a methyl group at the 2-or 3-position of the pyridine ligand leads to a strong decrease in cytotoxicity while a methyl group in the 4-position has little effect on activity. [5] Thus, steric effects also appear to play a role in the light activation of these photolabile Pt complexes.
To understand better the influence of ligand basicity, lipophilicity and steric effects on Binding of Pt to DNA is commonly associated with the anticancer activity of cisplatin and related analogues. [6, 7] Thus, in addition studying the cytotoxic effects on cancer cell lines we have also characterized the interactions between DNA and the photoactivated Pt IV diazides in order to investigate similarities and differences in binding that might explain some of the biological effects of these compounds.
Materials and methods
Caution! Although no problems were encountered during this work, heavy metal azides are known to be shock-sensitive detonators, therefore it is essential that any platinum azide compound is handled with care.
Chemicals and cell lines
Cisplatin was from Chempur (Karlsruhe, Germany). Oxoplatin was a gift of the RIEMSER Arzneimittel AG, Germany. Compounds 3 and 4 were synthesized as previously described. [3, 4] Stock solutions of cisplatin and oxoplatin were prepared in DMF (Sigma) and stored at -20 °C. All culture reagents were obtained from Sigma-Aldrich.
To investigate the phototoxic potency of the compounds, six different human cancer cell lines were used: 5637 (bladder), Kyse-70 (esophageal), SISO (cervix adenocarcinoma), DAN-G (pancreatic), A-427 (lung) and HL-60 (acute myeloid leukemia). All cell lines were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). A mycoplasma screen was done by using the Hoechst staining method and all cell lines where found to be free of mycoplasms. The oxoplatin resistant cell lines 5637-OXO, SISO-OXO and Kyse-70-OXO were established by weekly exposures to oxoplatin over several months and were resistant to both oxoplatin and cisplatin.
Light Source
Luzchem Expo panels (Luzchem Reasearch Inc., Ontario, Canada) were used for irradiation. The two Expo panels were accommodated with five fluorescent lamps each, 8 W per lamp. UVB radiation was cut off by a filter. The light source was positioned 25 cm away from the samples giving an intensity of 0.12 mW/cm 2 . Cool white fluorescent mercury tubes, 8 W, where used for irradiation with white light (intensity of 0.65 mW/cm 2 ). The above described set up was used in all cell experiments. All other experiments were irradiated using the LZC-4V illuminator (photoreactor) (Lutzchem, Canada) with temperature controller and UVA tubes (2 mW/cm 2 ; λ max = 365 nm).
Preparation of 5
Compound 5 was prepared in a three step synthesis: 
Measurement of log P
To determine the partition coefficient (P) the shake flask method was used. Water and n-octanol were pre-saturated with n-octanol and water, respectively. Compounds were first dissolved in water. Three different ratios of octanol/water were used (e.g. 1:1; 1:2 and 2:1).
Mixing was done by vortexing for 30 min at room temperature to establish the partition equilibrium. To separate the phases, centrifugation was done at 3,000 g for 5 min. The platinum concentrations in both phases were determined by flameless atomic absorption spectroscopy (FAAS) with a UNICAM 989 QZ spectrometer.
Theoretical calculations
All calculations were performed with the Gaussian 03 (G03) program [10] employing the DFT method, the PBE1PBE [11] functionals. The LanL2DZ basis set [12] and effective core potential were used for the Pt atom and the 6-31G**+ basis set [13] was used for all other atoms. Geometry optimizations of 5 in the ground state (S 0 ) and lowest-lying triplet state (T 1 )
were performed in the gas phase and the nature of all stationary points was confirmed by normal mode analysis. For the T 1 geometries the UKS method with the unrestricted PBE1PBE functional was employed. The conductor-like polarizable continuum model method (CPCM) [14] with water as solvent was used to calculate the electronic structure and the excited states of 5 in solution. Thirty-two singlet and eight triplet excited states with the corresponding oscillator strengths were determined with a Time-dependent Density Functional Theory (TDDFT) calculation. [15, 16] The computational results are summarized in the Supporting Information.
Cell growth inhibition with the crystal violet method
Cells were grown in medium containing 90% RPMI 1640 medium and 10% FCS, supplemented with penicillin G (30 mg/l) / streptomycin (40 mg/l) and kept at 37 °C in humidified atmosphere of 5% carbon dioxide/air.
In testing for antiproliferative activity, cells were seeded out in 96-well microtiter plates in 100 µl medium at a density of 1000 cells/well. The plates were returned to the incubator for 24 h. On the day of testing, the stock solutions of cisplatin (20 mM in DMF)
were serially diluted two fold in DMF to the desired concentration range, giving a series of five dilutions. Compounds 3, 4, and 5 were dissolved in water followed by sterile filtration immediately. Stock solutions and the dilutions were directly diluted 500-fold into medium. 
Cell growth inhibition with MTT method
The MTT assay was used for determining cytotoxicity in the suspension of cancer cell line HL-60. Cells were seeded out in 96-well microtiter plates in 50µl medium at a density of 10,000 cells/well. Dilutions of the compounds in cell culture medium were added directly to the cultures after seeding. Pretreatment was for 1 h, irradiation with UVA was for 30 min, 
Determination of oxoplatin cross-resistance
The IC 50 values of 4 and 5 were determined in three different oxoplatin-resistant human cancer cell lines. The three resistant cell lines were developed in our lab from the wildtype cell lines. The resistance factor (RF) was calculated as follows:
IC 50-oxoplatin resistant represents the IC 50 value for the oxoplatin resistant cell line and IC 50-wildtype stands for the IC 50 value for the wild-type line. The IC 50 values were determined as described above by the crystal violet assay. Resistance is said to occur when the RF value is greater than 1.5. For comparison, cisplatin and oxoplatin were used.
Clonogenic Assay
The Intracellular platinum concentrations were analyzed by flameless atomic absorption spectroscopy (AAS) as previously described. [19] The results were expressed in terms of ng platinum/1 million cells. Solutions of double-helical calf thymus DNA were incubated with 4, 5 or cisplatin at the r i value 0.1 in 10mM NaClO 4 at 37 ºC (r i is defined as the molar ratio of free platinum complex to nucleotides at the onset of incubation with DNA). Immediately after mixing, the solutions containing 4 or 5 were irradiated with UV light for 30 min and then placed in the dark at 37 ºC. Cisplatin-containing solutions were kept in the dark for the whole incubation period. At various time intervals, an aliquot of the reaction mixture was withdrawn and assayed by SW-voltammetry for platinum non-bound to DNA.
Polarographic measurement of Pt

Ethidium bromide fluorescence studies with DNA
In all studies, calf thymus DNA (0.04 mg/ml) was incubated with the platinum complex in 10 mM NaClO 4 at 37 °C for 24 h. 
The number of nucleotide residues in the plasmid pUC19 is 5,372. The fraction of DNA molecules corresponding to the non-cross-linked DNA is symbolized with ss, the ration of platinum compound to DNA is given by r b. [20, 21] 
Statistical analysis
All cell experiments were independently repeated at least three times. The IC 50 values along with the respective standard deviations were calculated with the software EXCEL (V Microsoft®).
Results
Synthesis of trans, trans, trans-[Pt(N 3 ) 2 (OH) 2 (NH 3 )(pip)]
The synthesis of 5 was carried out by a method analogous to that used to synthesize 4. 
Log P determinations
The log P value plays an important role in ADME studies (Absorption, Distribution, Metabolism and Excretion) and drug discovery. [22] The traditional shake flask method was used to measure the partition coefficient (P) between n-octanol and water.
The log P value of -2.21 ± 0.08 we obtained for cisplatin is within the range reported in the literature; i.e., -2.19 and -2.53. [23] [24] [25] [26] This value was constant irrespective of whether chloride (100 mM) was present or not. Complexes 4 and 5 are expected to be inert and very stable in water. The log P for the trans diammine complexe 3 was found to be -2.51 ± 0.14 and is thus even more hydrophilic than cisplatin. For 4 and 5 the log P are -1.84 ± 0.06 and -1.16 ± 0.03, respectively. These results are consistent with the order of the log P values of the respective amine ligands: pyridine (0.65) < piperidine (0.84) [27, 28] , but the relative difference is greater for the Pt complexes than would be expected from the amine ligands alone.
Theoretical calculations
Thirty-two singlet excited state transitions were calculated by TDDFT to assign the experimental bands in the UV-Vis spectrum of complex 5. Calculation of the lowest-lying triplet geometry can be highly informative [31] [32] [33] about the photochemistry of metal complexes. Such a state is generally populated in d 6 -metal complexes upon excitation and subsequent intersystem-crossing. [5] As already observed for other Pt IV -azides derivatives, the lowest-lying geometry of 5 is highly distorted (see supporting information). [30] In fact, the two Pt-N 3 bond distances are elongated by 0.29 Å and 0.42 Å compared to the ground state geometry, possibly indicating that release of azide ligands can occur via triplet formation.
Interestingly, in the triplet geometry the Pt center displays a significantly lower positive charge with respect to the ground state. Such behavior is consistent with the reduction from Pt IV to Pt II observed for Pt IV -azido complexes.
Influence of light on the cytotoxicity of Pt
IV -diazides
The human bladder cancer cell line 5637 was used to study the time- Table 1 also shows that compared to cisplatin, the potency of the light-activiated PtIV complexes is 10-20 fold less under identical test conditions (i.e., 30 min irradiation, then 6 h exposure to drug followed by 90 h cell growth without drug). However, cisplatin showed the same potency in both the light as in the dark, while 4 and 5 are only active when irradiated for 30 min.
Table 1
In studies designed to measure the optimal duration of irradiation, it was found that compound 5 is more rapidly activated than 4; i.e., only a 10 min irradiation with UVA is required to activate 5 to the same antiproliferative activity as a 30 min irradiation of 4.
( Figure 3 ) This effect was noticeable with both UVA and white light. Thus the introduction of the piperidine ligand leads to a compound that is more efficiently activated by light.
Figure 3
The use of UVA radiation in a therapeutic context is less desirable than longer wavelength light due to the low penetration of UVA into tissue. [35, 36] In order to reach deeper laying tumor tissues, light with longer wavelength is required. Thus, the activation of 4
and 5 was studied with white fluorescent light. resistance to oxoplatin, a cisplatin Pt IV prodrug, [37] in three oxoplatin resistant cell lines (SISO, KYSE70, 5637). In these cell lines cisplatin is cross resistant to oxoplatin (2-to 3.4-fold resistant). This is consistent with the hypothesis of oxoplatin being a prodrug of cisplatin.
On the other hand, 4 and 5 did not show any cross resistance to oxoplatin. (Table 1) 
Clonogenic assay in the human cervix adenocarcinoma cancer cell line SISO
The clonogenic assay is an in vitro cell survival assay based on the ability of a single cell to grow into a colony and is used to determine cell reproductive death after treatment with cytotoxic agents or ionizing radiation. It represents a more appropriate method than a simple antiproliferative assay to predict antitumor activity. [18, 38] respectively.
Figure 5
It has been reported that extracellular concentrations of chloride (e.g. 100 mM) can protect DNA from platination by cisplatin.
[40] Likewise, we found that when 100 mM chloride was present in the solutions of DNA, very little platination took place with UVAactivated 4 and 5. Due to the high chloride concentration, the equilibrium between chlorido and aqua Pt II species is shifted towards the less reactive chlorido species. When cisplatin enters the cell the chloride concentration drops to 4 -20 mM and the equilibrium shifts to aqua species that bind irreversibly to DNA. Because the same inhibitory effect of chloride was observed with 4 and 5, it would appear that UVA-activation also leads to the formation of reactive aqua species that can bind irreversibly to DNA.
Characterization of DNA adducts by ethidium bromide fluorescence.
The fluorescent dye ethidium bromide (EtBr) can be used to distinguish between with DNA binding that involves a combined intercalation/coordination mode similar to that observed for some cationic platinum(II) complexes that carry ethidium [44] or quinoline [46] as a nonleaving group (ethidium and quinoline are well known DNA intercalators which extensively unwind DNA).
Figure 7
The While this is a drastic reduction in activity compared to cisplatin, the clinically used analog of cisplatin, carboplatin, also shows 10-fold greater IC 50 values compare to cisplatin in our cell lines. [34] However, carboplatin shows reduced side-effects compared to cisplatin, making it a useful therapy for cancer. Thus, not the absolute potency is critical for anticancer activity but rather width of the therapeutic index, and light activated platinum complexes would be expected to have a wider therapeutic index than platinum complexes that are not selectively activated.
One possible advantage of 5 over 4 could be that the former requires less irradiation to reach the same level of antiproliferative activity as the latter. This may be due to the lower hydrophilicity of 5 compared to 4, which might allow it to cross cell membranes more rapidly.
However, Pt uptake studies showed that neither 4 nor 5 are taken up to any appreciable amount by cells in the dark. When both are UVA-activated, the rate of uptake of platinum by 5637 cells is similar for 4 and 5. This indicates that the photolysis products are selectively taken accumulated by cells while the starting complexes are not. Cisplatin, in contrast, is taken up by cells in the dark to roughly the same levels as light-activated 4 and 5 after 6 h, but shows no signs of plateauing after this time as 4 and 5 did. Likewise, cisplatin showed no difference between antiproliferative potency in the dark or with UVA irraditation.
Like cisplatin both compounds are able to bind irreversibly to DNA after they are photoactivated. This finding suggests that DNA could be one of the targets for the cytotoxic activity, but does not rule out others. UVA irradiation of either 4 or 5 brings about a very rapid platination calf thymus DNA compared to cisplatin; i.e., cisplatin has a half-life of binding of ca. 180 min, while for 4 and 5 the half-life of binding is less than 5 min. A fast binding mechanism was also described previously for 4 [3] , suggesting a novel mechanism of binding Pt to DNA. Nevertheless, the addition of chloride to the DNA solutions prevented binding of Pt to DNA, providing evidence that, like cisplatin, Pt-aqua species are intermediates in the pathway to DNA platination. Moreover, both 4 and 5 showed a similar interstrand-cross-linking efficiency (ca. 5%) compared to cisplatin (ca. 6%), suggesting that the main interactions with DNA are either monofunctional adducts or intrastrand crosslinks.
Interstrand crosslinks would be expected to displace ethidium bromide from its intercalation sites in B-DNA and indeed this is observed with both 4 and 5. The intrastrand crosslinks caused by cisplatin are known to result in the unwinding of super coiled, double stranded DNA, and indeed this was also observed to an even greater extent with both 4 and 5. Thus, the evidence on interactions with DNA strongly suggests that intrastrand crosslinks are important binding modes for both 4 and 5.
Nevertheless, the data for three oxoplatin resistant cell lines show no cross-resistance with 4 and 5, which is inconsistent with the Pt species arising from photolysis acting in a similar way to cisplatin. Alternative mechanisms of cytotoxicity could involve the release of highly reactive azide radicals, which could bring about lipid peroxidation of cell membranes, nitrenes or involve attack on proteins. Further data are needed to verify this idea.
In conclusion, by substituting the pyridine ligand with piperidine a photoactivatable Pt IV diazide was obtained that is less hydrophilic and has a more rapid rate of light activation to cytotoxic species. However, in all other cellular and biochemical aspects (e.g., cellular uptake, kinetics of DNA platination, DNA crosslinks, DNA unwinding, ect.) the behavior of the piperidine complex is similar to that of the pyridine analogue. Thus, the steric bulk of the ligand, not the base strength, appears more important for activity of this new class of photoactivatable anticancer agents.
